On Day 3, the panel discussed the challenges and potential solutions in managing sickle cell disease, with a focus on improving access to care, advancing research, and addressing stigma. They highlighted the importance of education, community engagement, and the establishment of post-transplant clinics to improve patient outcomes. The meeting also featured discussions on emerging research areas, including pharmacogenomics, and the importance of solidarity and learning from patient experiences.